Periorbital Red Light Therapy
Periorbital photobiomodulation targets the thinnest skin on the body — roughly 0.5mm at the tear trough — with 660nm and 850nm photons calibrated for the orbital bone. Unlike full-face panels, the 888-LENS concentrates >30 mW/cm² over approximately 12 cm² of periorbital tissue. The result: collagen synthesis at 200–500 microns and vasodilation at 300–800 microns, where creams cannot reach.
About this topic
Periorbital red light therapy is the targeted application of photobiomodulation (PBM) to the orbital bone, tear trough, and surrounding periorbital tissue using clinically validated wavelengths of 660nm (red) and 850nm (near-infrared). The periorbital region contains the thinnest skin on the human body (approximately 0.5mm at the tear trough), making it uniquely responsive to light therapy — photons reach dermal fibroblasts at 200–500 microns and capillary beds at 300–800 microns with minimal attenuation. Clinical evidence demonstrates that dual-wavelength periorbital PBM stimulates collagen synthesis in the papillary dermis (660nm, 0.5–2mm depth) while simultaneously improving microcirculation via nitric oxide-mediated vasodilation in deeper tissue (850nm, 2–5mm depth). This combination addresses the root mechanisms of periorbital aging: collagen degradation, hemoglobin pooling, and volume loss.